Top Markets
#1 Black Phoenix Black Phoenix +346.11%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +67.06%
#4 Gold Park Gold Park +58.03%
#5 Acurast Acurast +36.59%
#6 OpenEden OpenEden +32.83%
#7 BasedHype BasedHype +27.23%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.76%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +16.89%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Classifica tra le azioni #40710
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Prezzo delle azioni
$0.065
Ultima sincronizzazione: 2025-01-10
Capitalizzazione di mercato
$94.10K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia TFF Pharmaceuticals, Inc. (TFFP)

Categoria

Healthcare
Il prezzo TFFP con la capitalizzazione del mercato della B
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
TFFP
$0.065
Capitalizzazione di mercato di TFF Pharmaceuticals, Inc.(TFFP)
Capitalizzazione di mercato: $94.10K
A partire dal August 2026, TFF Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $94.10K. Questo rende TFF Pharmaceuticals, Inc. la 40710th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di TFF Pharmaceuticals, Inc. dal 2019 al 2026
TFFP in paragone con la classifica dei più popolari stocks
Il prezzo per TFFP Attivo B Capitalizzazione del mercato a B Risultati
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,775,383 $94.10K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.466T +5,808,281,050.57%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,077,935 $94.10K
Apple Inc. Apple Inc.
AAPL
$4.456T +4,735,284,137.96%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,883,583 $94.10K
Alphabet Inc. Alphabet Inc.
GOOG
$4.175T +4,436,281,069.66%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,547,265 $94.10K
Microsoft Corporation Microsoft Corporation
MSFT
$3.688T +3,918,868,801.49%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$1,978,704 $94.10K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.865T +3,044,160,226.98%